Respirable antisense oligonucleotides: a new drug class for respiratory disease

Respirable antisense oligonucleotides (RASONs), which attenuate specific disease-associated mRNAs, represent a new class of respiratory therapeutics with considerable potential. RASONs overcome previous obstacles that have impeded the development of antisense therapeutics targeting diseases in other...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Makoto, Nyce, Jonathan W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59563/
https://www.ncbi.nlm.nih.gov/pubmed/11686859
http://dx.doi.org/10.1186/rr32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59563/
https://www.ncbi.nlm.nih.gov/pubmed/11686859
http://dx.doi.org/10.1186/rr32

Ejemplares similares